Biomet source of Medtronic Sofamor Danek's latest legal woes
This article was originally published in Clinica
Executive Summary
Not only is Medtronic Sofamor Danek (MSD) facing a considerable damages pay-out to an inventor of some of its spinal technology, but it has also lost a separate case against rival firm Biomet. It has been ordered to stop making and selling a number of its polyaxial screws, under a permanent injunction obtained by Biomet company Cross Medical Products.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.